World Health Organization. WHO Expert Consultation on Rabies: Third Report. (World Health Organization, Geneva, 2018).

Rabies. https://www.who.int/news-room/fact-sheets/detail/rabies.

Gilbert, A. T. Rabies virus vectors and reservoir species. Rev. Sci. Tech. Int. Off. Epizoot 37, 371–384 (2018).

Article  CAS  Google Scholar 

Ly, S. et al. Rabies situation in Cambodia. PLoS Negl. Trop. Dis. 3, e511 (2009).

Article  PubMed  PubMed Central  Google Scholar 

Chevalier, V. et al. Large scale dog population demography, dog management and bite risk factors analysis: a crucial step towards rabies control in Cambodia. PLoS ONE 16, e0254192 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gan, H. et al. Global burden of rabies in 204 countries and territories, from 1990 to 2019: results from the Global Burden of Disease Study 2019. Int. J. Infect. Dis. 126, 136–144 (2023).

Article  PubMed  Google Scholar 

World Health Organization null. Rabies vaccines: WHO position paper, April 2018 - Recommendations. Vaccine 36, 5500–5503 (2018).

Article  CAS  PubMed  Google Scholar 

Cantaert, T. et al. A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study. Lancet Infect. Dis. 19, 1355–1362 (2019).

Article  CAS  PubMed  Google Scholar 

Gholami, A. et al. Seroconversion after three doses of intramuscular rabies vaccine as a post-exposure treatment. Virus Res. 278, 197883 (2020).

Article  CAS  PubMed  Google Scholar 

World Health Organization. WHO Expert Committee on Biological Standardization: fifty-sixth report. (2007).

Rao, A. K. et al. Use of a modified preexposure prophylaxis vaccination schedule to prevent human rabies: recommendations of the advisory committee on immunization practices—United States, 2022. Morb. Mortal. Wkly. Rep. 71, 619–627 (2022).

Article  CAS  Google Scholar 

Hooper, D. C. et al. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J. Virol. 72, 3711–3719 (1998).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gnanadurai, C. W. et al. Presence of virus neutralizing antibodies in cerebral spinal fluid correlates with non-lethal rabies in dogs. PLoS Negl. Trop. Dis. 7, e2375 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Khawplod, P. et al. Revision of the Thai Red Cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection. Vaccine 24, 3084–3086 (2006).

Article  PubMed  Google Scholar 

Thraenhart, O. et al. Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man. Clin. Immunol. Immunopathol. 71, 287–292 (1994).

Article  CAS  PubMed  Google Scholar 

De Pijper, C. A. et al. Long-term memory response after a single intramuscular rabies booster vaccination 10-24 years after primary immunization. J. Infect. Dis. 226, 1052–1056 (2022).

Article  PubMed  Google Scholar 

Hu, J. et al. Long-term immunity and the effect of one or two booster doses with a lyophilized human rabies vaccine (human diploid cells) at 10 years post primary vaccination in China. Hum. Vaccines Immunother. 17, 3162–3168 (2021).

Article  CAS  Google Scholar 

Barkhouse, D. A., Faber, M. & Hooper, D. C. Pre- and post-exposure safety and efficacy of attenuated rabies virus vaccines are enhanced by their expression of IFNγ. Virology 0, 174–180 (2015).

Article  CAS  Google Scholar 

Barkhouse, D. A. et al. Expression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon. J. Virol. 89, 312–322 (2015).

Article  PubMed  Google Scholar 

Lafon, M. Modulation of the immune response in the nervous system by rabies virus. Curr. Top. Microbiol. Immunol. 289, 239–258 (2005).

CAS  PubMed  Google Scholar 

Katz, I. S. S., Guedes, F., Fernandes, E. R. & Dos Ramos Silva, S. Immunological aspects of rabies: a literature review. Arch. Virol. 162, 3251–3268 (2017).

Article  CAS  PubMed  Google Scholar 

Phares, T. W., Kean, R. B., Mikheeva, T. & Hooper, D. C. Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J. Immunol. Baltim. Md. 176, 7666–7675 (2006).

CAS  Google Scholar 

Phares, T. W., Fabis, M. J., Brimer, C. M., Kean, R. B. & Hooper, D. C. A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient. J. Immunol. Baltim. Md. 178, 7334–7343 (2007).

CAS  Google Scholar 

Gnanadurai, C. W. & Fu, Z. F. CXCL10 and blood-brain barrier modulation in rabies virus infection. Oncotarget 7, 10694–10695 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Wang, H. et al. Intracerebral administration of recombinant rabies virus expressing GM-CSF prevents the development of rabies after infection with street virus. PLOS ONE 6, e25414 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hooper, D. C. et al. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 14, 691–698 (2000).

CAS  Google Scholar 

Overduin, L. A., van Dongen, J. J. M. & Visser, L. G. The cellular immune response to rabies vaccination: a systematic review. Vaccines 7, 110 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilde, H., Khawplod, P. & Hemachudha, T. Post-exposure rabies prophylaxis in patients with AIDS. Vaccine 27, 5726–5727 (2009).

Article  PubMed  Google Scholar 

Tantawichien, T., Jaijaroensup, W., Khawplod, P. & Sitprija, V. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 33, E122–E124 (2001).

Article  CAS  Google Scholar 

Pancharoen, C. et al. Failure of pre- and postexposure rabies vaccinations in a child infected with HIV. Scand. J. Infect. Dis. 33, 390–391 (2001).

Article  CAS  PubMed  Google Scholar 

Herzog, M. et al. T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination. Clin. Exp. Immunol. 85, 224–230 (1991).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wijaya, L. et al. An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteers. Vaccine 35, 1175–1183 (2017).

Article  CAS  PubMed  Google Scholar 

Auerswald, H. et al. Side-by-side comparative study of the immunogenicity of the intramuscular and intradermal rabies post-exposure prophylaxis regimens in a cohort of suspected RABV exposed individuals. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. ciad304 https://doi.org/10.1093/cid/ciad304 (2023).

Venkataswamy, M. M. et al. Cellular immune response following pre-exposure and postexposure rabies vaccination by intradermal and intramuscular routes. Clin. Exp. Vaccine Res. 4, 68–74 (2015).

Article  PubMed  PubMed Central  Google Scholar 

World Organisation for Animal Health. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. in Chapter 3.1.18. Rabies (Infection with Rabies Virus and Other Lyssaviruses) (WOAH, 2023).

Tantawichien, T. et al. Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis. Expert Rev. Vaccines 13, 1593–1601 (2014).

Article  CAS  PubMed  Google Scholar 

Ashwathnarayana, D. H. et al. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab). Vaccine 28, 148–151 (2009).

Article  PubMed